Vivos Therapeutics, Inc. Share Price
Stocks
VVOS
US92859E2072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1337 USD | +0.91% |
|
+1.98% | -93.41% |
| 10-19 | Vivos Therapeutics Buys 11% of SOD Sciences, Gains 50% Stake in Diagnostic Test | MT |
| 09-29 | Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives | CI |
| Market Cap | 2.69M 2.4M 2.22M 2.01M 3.76M 255M 3.82M 26.7M 10.57M 134M 10.09M 9.88M 422M | P/E 2026 * |
-0.1x | P/E 2027 * | -0.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.69M 2.4M 2.22M 2.01M 3.76M 255M 3.82M 26.7M 10.57M 134M 10.09M 9.88M 422M | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.08x |
| Free-Float |
88.68% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VVOS | Delayed | |
CBOE
| VVOS | Real-time |
Last Transcript: Vivos Therapeutics, Inc.
| 1 day | +0.91% | ||
| 1 week | +1.98% | ||
| Current month | -9.60% | ||
| 1 month | -8.11% | ||
| 3 months | -65.99% | ||
| 6 months | -84.13% | ||
| Current year | -93.41% |
| 1 week | 0.12 |  | 0.14 |
| 1 month | 0.12 | | 0.16 |
| Current year | 0.12 | | 2.69 |
| 1 year | 0.12 | | 3.05 |
| 3 years | 0.12 | | 48.79 |
| 5 years | 0.12 | | 106.75 |
| 10 years | 0.12 | | 360.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Huntsman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Susan McCullough
COO | Chief Operating Officer | - | 31/08/2016 |
R. Huntsman
CEO | Chief Executive Officer | 68 | 31/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
R. Huntsman
CHM | Chairman | 68 | 31/05/2020 |
Ralph Green
BRD | Director/Board Member | 87 | 31/05/2020 |
Anja Krammer
BRD | Director/Board Member | 59 | 31/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/09/26 | Other | Director | 12,000 | 0.0596% | ||
| 14/09/26 | Free | Director | 12,000 | 0.0596% | ||
| 31/07/26 | Free | Chief Financial Officer | 400,000 | 2.8788% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.91% | +1.98% | -95.56% | -97.96% | 2.69M | |
| +1.16% | -1.13% | -18.25% | +9.38% | 179B | |
| +0.02% | +4.24% | -19.55% | +15.88% | 118B | |
| -1.22% | +0.70% | +1.86% | +32.59% | 117B | |
| +2.29% | +17.36% | -42.18% | +8.22% | 93.26B | |
| -2.21% | -2.91% | -0.51% | +75.12% | 63.16B | |
| -1.06% | +1.75% | +13.48% | +74.12% | 55.68B | |
| -0.75% | +3.73% | +7.04% | -23.26% | 54.18B | |
| -1.13% | +0.00% | -12.56% | +30.09% | 44.15B | |
| +0.17% | +5.85% | -5.20% | -11.43% | 33.95B | |
| Average | -0.18% | +3.44% | -17.14% | +11.27% | 75.84B | |
| Weighted average by Cap. | -0.00% | +3.09% | -11.77% | +21.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.79M 19.46M 17.98M 16.29M 30.48M 2.07B 30.98M 216M 85.64M 1.08B 81.77M 80.03M 3.42B | 34.09M 30.44M 28.12M 25.48M 47.68M 3.24B 48.47M 338M 134M 1.7B 128M 125M 5.35B |
| Net income | -23.53M -21.01M -19.41M -17.59M -32.91M -2.23B -33.46M -234M -92.49M -1.17B -88.32M -86.44M -3.69B | -14.7M -13.13M -12.13M -10.99M -20.57M -1.4B -20.91M -146M -57.79M -731M -55.18M -54.01M -2.31B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | US$0.1337 | +0.91% | 936,317 |
| 22/10/26 | US$0.1325 | -1.63% | 1,927,622 |
| 21/10/26 | US$0.1347 | -4.20% | 4,717,135 |
| 20/10/26 | US$0.1406 | +4.23% | 76,703,159 |
| 19/10/26 | US$0.1349 | +2.90% | 47,333,843 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VVOS Stock
Select your edition
All financial news and data tailored to specific country editions
